Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
   
Ask the Experts About

Choosing Your MedsChoosing Your Meds
          
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  
  • Email Email
  • Glossary Glossary


NEW COMBO
Mar 29, 2002

Dear Docs, I have been + for about 5 years now. I recently swithced out Zerit in favor of Viread, due to some lipodystropy issues. I am still on the Sustiva and 3TC. Blood work recently back VL 623, and CD4 at over 1300. I have been taking this combo for the past 6 weeks prior to the lab work. I never go to below 50 copies on anything is this of any concern. Thank-You in Denver.

Response from Dr. Boyle

Yes, it is. Your doctor should evaluate your past antiretroviral therapy carefully and consider trying to get a resistance test (sometimes you can get one between 500 and 1000 copies/mL) to guide further therapy choices. A viral load like yours is likely to lead to the development of higher levels of resistance, and eventually immunologic failure, and that may further affect your future treatment options and chances for success.



Previous
Videx/Epivir okay?
Next
switching to trisivir

  
  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS


 
Advertisement



Q&A TERMS OF USE

This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint

Advertisement